KDRA to move forward study on new biopharmaceuticals

Published: 2013-07-16 06:59:00

Updated: 2013-07-16 06:59:00

The Korea Drug Research Association (KDRA) will conduct a study on the feasibility of new biotech projects in seven sectors – low molecular weight drugs, natural products, biological drugs, antibodies, regenerative drugs, drug platform technologies and other chemical products, officials said Mond...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK